Pursuant to Regulation 30(2) read with Schedule III Part A Para A(15) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lupin has informed that it enclosed the investor presentation which will be made at the J. P Morgan Healthcare Conference, US on January 10, 2023.
The above information is a part of company’s filings submitted to BSE.